Our publications
The german federal government officially ratified the UPC act of approval on august 13th
The publication of the law in the Federal Law Gazette finally puts an end to the legal complications that have been blocking the german ratification process and, consequently, the establishment of the Unified Patent +
Again, and again: the UPC agreement is further challenged in Germany
Although the German Parliament («Bundesrat») recently voted in favor of the ratification of the Unified Patent Court Agreement (UPCA) (that we reported here), and despite the political will (see there), the German ratification of the UPCA +
EPO announces raise of fees from 1 april 2022
The EPO’s Rules relating to Fees have been amended by decision of the Administrative Council of 15 December 2021. The amended version of the Rules relating to Fees is applicable as from 1 April +
Preparation for the european patent with unitary effect at the EPO
The European Patent with unitary effect (“Unified Patent”) will be introduced soon. The final stage of the preparatory work will be accomplished by the end of this summer and the final missing ratification will +
Artificial intelligence system DABUS
Artificial intelligence system called DABUS cannot be named as inventor according to Decisions J 8/20 and J 9/20 of the Board of Appeal of the EPO Legal background Article 81 EPC stipulates that the +
Pharmaceutical trademarks and INPI applications for revocation (Loi Pacte)
I. Assessment of use with respect to products In our previous review of case law on pharmaceutical trademarks, we examined the differences in practice between the European Union and French courts in identifying the +
European Patent Office rated top for patent and service quality
The Intellectual Asset Management (IAM) once again initiated a benchmarking survey and let users vote among the world's five largest patent offices for the quality of its patents and services. Again, the EPO has +
Newsletter
sign-up